Thu 24 Sep 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| FEBUXOSTAT | Resilia | 40 | Film-coated tablet | 87.00 | Details |
| TENOFOVIR DISOPROXIL | Hivera | 300 | Film-coated tablet | 783.65 | Details |
| CISATRACURIUM | Bexenta | 2 | Solution for injection | 69.85 | Details |
| PEMETREXED | Alix | 500 | Lyophilisate for solution for injection | 2595.15 | Details |
| VORICONAZOLE | VFEND 40MG/ML POWDER FOR SUSPENSION | 40 | Powder for oral suspension | 1470.25 | Details |
| PARACETAMOL | Panamol | 10 | Intravenous infusion | 17.30 | Details |
| PEGCETACOPLAN | Empaveli 1080 mg per 20 ml | 54 | Solution for infusion | 16289.60 | Details |
| PEGCETACOPLAN | Empaveli 1080 mg per 20 ml 8 vials | 54 | Solution for infusion | 130364.90 | Details |
| TADALAFIL | Starkoprex | 20 | Film-coated tablet | 64.85 | Details |
| FENTANYL | FENTANYL MEDIS 10 ml Ampoule | 50 | Solution for injection | 63.80 | Details |
| FENTANYL | FENTANYL MEDIS 2 ml Ampoule | 50 | Solution for injection | 25.85 | Details |
| ENTRECTINIB | Rozlytrek | 100 | Capsule, hard | 3444.35 | Details |
| ENTRECTINIB | Rozlytrek | 200 | Capsule, hard | 20653.45 | Details |
| RISDIPLAM | Evrysdi 60 mg/80ml | 0.75 | Powder for oral solution | 40090.20 | Details |
| GEMCITABINE | Gemcitabine BOS | 1000 | Concentrate for solution for infusion | 242.5 | Details |
| LOMITAPIDE MESYLATE | Lojuxta | 5 | Capsule, hard | 91051.30 | Details |
| LOMITAPIDE MESYLATE | Lojuxta | 10 | Capsule, hard | 91051.30 | Details |
| LOMITAPIDE MESYLATE | Lojuxta | 20 | Capsule, hard | 91051.30 | Details |
| LEVETIRACETAM | Kepavie | 500 | Film-coated tablet | 58.45 | Details |
| CEFEPIME HYDROCHLORIDE | Cefepime | 1000 | Powder for solution for injection/infusion | 29.00 | Details |
5.86% of users said yes from 273 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.